These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 38710029
41. Comparative efficacy and safety of lock solutions for the prevention of catheter-related complications including infectious and bleeding events in adult haemodialysis patients: a systematic review and network meta-analysis. Sheng KX, Zhang P, Li JW, Cheng J, He YC, Böhlke M, Chen JH. Clin Microbiol Infect; 2020 May; 26(5):545-552. PubMed ID: 31857208 [Abstract] [Full Text] [Related]
42. The CATERPILLAR study: an assessor-blinded randomized controlled trial comparing a taurolidine-citrate-heparin lock solution to a heparin-only lock solution for the prevention of central-line-associated bloodstream infections in paediatric oncology patients. van den Bosch CH, Loeffen YGT, van der Steeg AFW, van der Bruggen JT, Frakking FNJ, Fiocco M, van de Ven CP, Wijnen MHWA, van de Wetering MD. J Hosp Infect; 2024 Oct; 152():56-65. PubMed ID: 39004189 [Abstract] [Full Text] [Related]
45. Taurolidine lock solutions for the prevention of catheter-related bloodstream infections: a systematic review and meta-analysis of randomized controlled trials. Liu Y, Zhang AQ, Cao L, Xia HT, Ma JJ. PLoS One; 2013 Oct; 8(11):e79417. PubMed ID: 24278133 [Abstract] [Full Text] [Related]
46. Sodium citrate 4% versus heparin as a lock solution in hemodialysis patients with central venous catheters. Yon CK, Low CL. Am J Health Syst Pharm; 2013 Jan 15; 70(2):131-6. PubMed ID: 23292266 [Abstract] [Full Text] [Related]
49. Citrate versus heparin lock for prevention of hemodialysis catheter-related complications: updated systematic review and meta-analysis of randomized controlled trials. Mai H, Zhao Y, Salerno S, Li Y, Feng Y, Ma L, Fu P. Int Urol Nephrol; 2019 Jun 15; 51(6):1019-1033. PubMed ID: 31012037 [Abstract] [Full Text] [Related]
53. Low-dose versus high-dose heparin locks for hemodialysis catheters: a systematic review and meta-analysis. Han X, Yang X, Huang B, Yuan L, Cao Y. Clin Nephrol; 2016 Jul 15; 86(7):1-8. PubMed ID: 27191662 [Abstract] [Full Text] [Related]
58. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial. Garland JS, Alex CP, Henrickson KJ, McAuliffe TL, Maki DG. Pediatrics; 2005 Aug 15; 116(2):e198-205. PubMed ID: 15995005 [Abstract] [Full Text] [Related]
59. Randomised clinical trial: 2% taurolidine versus 0.9% saline locking in patients on home parenteral nutrition. Wouters Y, Theilla M, Singer P, Tribler S, Jeppesen PB, Pironi L, Vinter-Jensen L, Rasmussen HH, Rahman F, Wanten GJA. Aliment Pharmacol Ther; 2018 Aug 15; 48(4):410-422. PubMed ID: 29978597 [Abstract] [Full Text] [Related]
60. Catheter salvage or removal in catheter-related bloodstream infections with Staphylococcus aureus in children with chronic intestinal failure receiving home parenteral nutrition and the use of prophylactic taurolidine catheter lock solution: A descriptive cohort study. Demirok A, Illy DHC, Nagelkerke SQ, Lagerweij MF, Benninga MA, Tabbers MM. JPEN J Parenter Enteral Nutr; 2024 May 15; 48(4):486-494. PubMed ID: 38605559 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]